Clinical cytological study of patients with ascites in a national general hospital in Peru
DOI:
https://doi.org/10.37711/rpcs.2022.4.1.365Keywords:
malignant ascites, cytological studyAbstract
Objective. To evaluate the sensitivity, specifcity and predictive values of the
clinical cytological study of patients with ascites in a national general hospital in Peru. Methods. Patients presenting with clinical manifestations of ascites, biochemical, cytological and histological studies were included. Results. Fifteen patients with ascites were studied. The mean age was 62 years, being 80% female and 20% male. The fnal diagnoses revealed various malignant neoplasms (93.3%) and peritoneal tuberculosis (6.7%). The most frequent clinical manifestation was mild to severe abdominal pain (80%). The cellular components were: red blood cells (73.3%), histiocytes (26.7%), lymphocytes (73.3%), polymorphonuclear cells (40%), mesothelial cells (86.7%) and clusters of epithelioid cells with varying degrees of atypia (80%). Two cases
showed atypical lymphoid cells. The sensitivity and positive predictive value
were 87% and 80%, respectively. Conclusions. According to a dichotomous test, the present study demonstrates the high sensitivity and high positive predictive value of the clinical cytologic study in patients with ascites
Downloads
References
Carrier P, Jacques J, Debette-Gratien M, Legros R, Sarabi M, Vidal E, et al. Non-cirrhotic ascites: pathophysiology, diagnosis and etiology. La Rev Med interne. 2014 Jun; 35(6): 365-71.
Plancarte R, Guillén MR, Guajardo J, Mayer F. Ascitis en los pacientes oncológicos: Fisiopatogenia y opciones de tratamiento. Rev la Soc Española del Dolor [Internet]. 2004 [Consultado 2020 jul 20]; 11: 156-62. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1134-80462004000300006&nrm=iso
Andrea M. Medina DFAC. Manejo de la ascitis maligna no refractaria. Rev clínica la Esc Med UCR-HSJD. 2014; 14(5): 7-17.
Suntur BM, Kuscu F. Pooled analysis of 163 published tuberculous peritonitis cases from Turkey. Turkish J Med Sci. 2018 Apr; 48(2): 311-7
Huamán N. Tuberculosis Intestinal y peritoneal. Rev Soc Peru Med Interna. 2002; 15(1): 8-14.
Bono MG, Gregori AE, Gonzalvo AF, Segarra AE, Alemany MS, Moral JVC. Tuberculosis peritoneal. Diagnóstico diferencial con carcinomatosis de origen ovárico. Progresos Obstet y Ginecol. 2013; 56(7): 378-81.
Lee Y-M, Hwang J-Y, Son S-M, Choi S-Y, Lee H-C, Kim E-J, et al. Comparison of diagnostic accuracy between CellprepPlus® and ThinPrep® liquid-based preparations in effusion cytology. Diagn Cytopathol. 2014 May; 42(5): 384-90.
Gong Y, Sun X, Michael CW, Attal S, Williamson BA, Bedrossian CWM. Immunocytochemistry of serous effusion specimens: A comparison of ThinPrep® vs. cell block. Diagn Cytopathol. 2003; 28(1): 1–5.
Hoda RS. Non-gynecologic cytology on liquid-based preparations: A morphologic review of facts and artifacts. Diagn Cytopathol. 2007 Oct; 35(10): 621-34.
Rossi ED, Fadda G. Thin-layer liquid-based preparation of non-gynaecological exfoliative and fine-needle aspiration biopsy cytology. Diagnostic Histopathol [Internet]. 2008 [Consultado 2020 jul 11]; 14(11): 563-70. Disponible en: http://www.sciencedirect.com/science/article/pii/S1756231708001540
Téllez L, Aicart-Ramos M, Rodríguez-Gandía MA, Martínez AAJ. Ascitis: diagnóstico diferencial y tratamiento. Medicine (Baltimore). 2016; 12(12): 673–82.
Wilailak S, Linasmita V, Srivannaboon S. Malignant ascites in female patients: a seven-year review. J Med Assoc Thai [Internet]. 1999 [Consultado 2020 jul 25]; 82(1): 15-9. Disponible en http://europepmc.org/abstract/MED/10087733
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov; 68(6): 394-424.
Oriuchi N, Nakajima T, Mochiki E, Takeyoshi I, Kanuma T, Endo K, et al. A new, accurate and conventional five-point method for quantitative evaluation of ascites using plain computed tomography in cancer patients. Jpn J Clin Oncol. 2005 Jul; 35(7): 386-90.
Sangisetty SL, Miner TJ. Malignant ascites: A review of prognostic factors, pathophysiology and therapeutic measures. World J Gastrointest Surg. 2012 Apr; 4(4): 87-95.
Schwensen JF, Bulut M, Nordholm-Carstensen A. Laparoscopy can be used to diagnose peritoneal tuberculosis. Ugeskrift for laeger. 2014; 176.
Wang H, Qu X, Liu X, Ding L, Yue Y. Female Peritoneal Tuberculosis with Ascites, Pelvic Mass, or Elevated CA 125 Mimicking Advanced Ovarian Cancer: A Retrospective Study of 26 Cases. J Coll Physicians Surg Pak. 2019 Jun; 29(6): 588-9.
Chandra A, Crothers B, Kurtycz D, Schmitt F. Announcement: The International System for Reporting Serous Fluid Cytopathology. Acta cytologica. 2019; 63: 349-51.
Chandra A, Crothers B, Kurtycz D, Fernando Schmitt F, editores. The International System for Serous Fluid Cytopathology [Internet]. Switzerland: Springer International Publishing; 2020 [Consultado 2020 jul 25]. Disponible en: https://www.springer.com/gp/book/9783030539078
Jha R, Shrestha HG, Sayami G, Pradhan SB. Study of effusion cytology in patients with simultaneous malignancy and ascites. Kathmandu Univ Med J (KUMJ). 2006; 4(4): 483-7.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Juan Carrasco, Walter Guitton, José Ernesto Raez, Edith Paz, Roger Verona, Elizabeth Neira, Dina Carayhua, Fernando Arévalo, Carlos Ernesto Nava, Carlos Barrionuevo
This work is licensed under a Creative Commons Attribution 4.0 International License.